CLINICAL_TRIALS
trial_result
· 2017-07-13
Clinical Trial Update: Trial of High-Dose Rifampin in Patients With TB [Phase 2]
Summary
Phase 2 trial assessing high-dose rifampin in patients with tuberculosis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Harvard University Faculty of Medicine | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2017-07-13